Måndag 8 Juni | 19:53:32 Europe / Stockholm

Prenumeration

Kalender

Est. tid*
2026-08-26 08:00 Kvartalsrapport 2026-Q2
2026-05-04 - Årsstämma
2026-03-31 - X-dag ordinarie utdelning FARON 0.00 EUR
2026-03-04 - Bokslutskommuniké 2025
2025-08-27 - Kvartalsrapport 2025-Q2
2025-03-24 - X-dag ordinarie utdelning FARON 0.00 EUR
2025-03-21 - Årsstämma
2025-02-27 - Bokslutskommuniké 2024
2024-08-28 - Kvartalsrapport 2024-Q2
2024-03-25 - X-dag ordinarie utdelning FARON 0.00 EUR
2024-03-22 - Årsstämma
2024-03-14 - Bokslutskommuniké 2023
2023-08-29 - Kvartalsrapport 2023-Q2
2023-03-27 - X-dag ordinarie utdelning FARON 0.00 EUR
2023-03-24 - Årsstämma
2023-03-03 - Bokslutskommuniké 2022
2022-08-25 - Kvartalsrapport 2022-Q2
2022-07-07 - Extra Bolagsstämma 2022
2022-04-25 - X-dag ordinarie utdelning FARON 0.00 EUR
2022-04-22 - Årsstämma
2022-03-25 - Bokslutskommuniké 2021
2021-08-26 - Kvartalsrapport 2021-Q2
2021-04-26 - X-dag ordinarie utdelning FARON 0.00 EUR
2021-04-23 - Årsstämma
2021-03-25 - Bokslutskommuniké 2020
2020-05-14 - X-dag ordinarie utdelning FARON 0.00 EUR
2020-05-13 - Årsstämma
2020-03-20 - Bokslutskommuniké 2019

Beskrivning

LandFinland
ListaFirst North Finland
SektorHälsovård
IndustriBioteknik
Faron Pharmaceuticals är verksamt inom medicinteknik. Bolaget bedriver forskning och utveckling av terapeutiska lösningar som används för behandling av immuna sjukdomar och diverse organskador. Störst verksamhet återfinns inom Nordamerika samt Europa, med sjukhus och forskningsinstitut som huvudsaklig kundbas. Utöver huvudverksamheten erbjuds diverse mervärdestjänster. Huvudkontoret ligger i Turku.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

2026-06-08 18:30:00

Faron Pharmaceuticals Ltd | Company announcement | June 08, 2026 at 19:30:00 EEST

Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS

1a. Identity of the issuer or the underlying issuer of existing shares:Faron Pharmaceuticals Oy
1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)
Non-UK issuerX
2. Reason for the notification (please mark the appropriate box or boxes with an “X”)
An acquisition or disposal of shares
An acquisition or disposal of financial instruments
An event changing the breakdown of shares outstandingX
Other (please specify):
3. Details of person subject to the notification obligation
NamePentwater Capital Management LP
City and country of registered office (if applicable)Naples, United States
4. Full name of shareholder(s) (if different from 3.)
Name
City and country of registered office (if applicable)
5. Date on which the threshold was crossed or reached:04/06/2026
6. Date on which issuer notified (DD/MM/YYYY):05/06/2026
7. Total positions of person(s) subject to the notification obligation

% of shares outstanding (total of 8. A)% of shares outstanding through financial instruments
(total of 8.B 1 + 8.B 2)
Total of both in % (8.A + 8.B)Total number of shares outstanding held in issuer
Resulting situation on the date on which threshold was crossed or reached
3.875746%3.875746%8,000,000.00
Position of previous notification (if
applicable)

4.342441%4.342441%
8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedv
A: Shares
Class/type of
shares
ISIN code (if possible)
Number of shares outstanding% of shares outstanding
Direct
Indirect
Direct
Indirect





SUBTOTAL 8. A

B 1: Financial Instruments as an entitlement to acquire
Type of financial instrumentExpiration
date
Exercise/
Conversion Period
Number shares that may be acquired if the instrument is
exercised/converted.
% of shares outstanding







SUBTOTAL 8. B 1

B 2: Financial Instruments with similar economic effect
Type of financial instrumentExpiration
date
Exercise/
Conversion Period
Physical or cash
settlement
Number of shares% of shares outstanding
Swap

Cash Settlement8,000,000.003.875746%









SUBTOTAL 8.B.28,000,000.003.875746%
9. Information in relation to the person subject to the notification obligation (please mark the
applicable box with an “X”)
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer
Full chain of controlled undertakings through which the shares and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entity(please add additional rows as necessary)
X
Name% of shares outstanding if it equals or is higher than the notifiable threshold% of shares outstanding through financial instruments if it equals or is higher than the notifiable thresholdTotal of both if it equals or is higher than the notifiable threshold
Matthew Halbower


MCH PWCM Holdings Inc.


Pentwater Capital Management LP
3.875746%3.875746%

10. Additional information

Place of completionNaples
Date of completion05/06/2026